N+1 Singer shares its Q1 2018 Review

In our Q1 2018 review, we discuss the UK  economic and equity market environment and notable transactions completed in the first quarter of 2018.

Hipgnosis Songs Fund Ltd Publicly Lists on the Specialist Fund Segment

Today marks the first day of dealings for Hipgnosis Songs Fund Ltd, as they list on the Specialist Fund Segment on the Main Market on the London Stock Exchange.   Founded by Merck Mercuriadis, former manager

Read More
[Video] N+1 Singer’s Emerging Companies Lunch

Last Thursday we held our second ‘Emerging Companies Lunch’ hosted at The NED, in the City of London. Our private company lunches pair up fast-growing private companies with fund managers focused on small cap opportunities. For

Read More
[Video] Mark Gibbon discusses the N+1 Singer Best Ideas H1 Review

Mark Gibbon, Head of Research at N+1 Singer, discusses the N+1 Singer Best Ideas H1 Review.  For more information, email enquiries@n1singer.com

Read More

Transaction Highlights


Date: July 2018

Sector: Chemicals  

Type: Placing

£4.4 million

Hipgnosis Songs Fund Ltd.

Date: July 2018

Sector: Investment Funds   

Type: Placing & Offer

£202 million

i-nexus Global Plc

Date: June 2018

Sector: Software & IT Services  

Type: Placing

£10.0 million

Communications about our events, transactions and industries.